Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 164

Similar articles for PubMed (Select 21550212)

1.

Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies.

Zuddas A, Zanni R, Usala T.

Eur Neuropsychopharmacol. 2011 Aug;21(8):600-20. doi: 10.1016/j.euroneuro.2011.04.001. Epub 2011 May 6. Review.

PMID:
21550212
2.

Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children.

Devlin AM, Panagiotopoulos C.

Pharmacogenomics. 2015 Jun 24:1-16. [Epub ahead of print]

PMID:
26107755
3.

Off-label prescribing of antipsychotics in adults, children and elderly individuals: a systematic review of recent prescription trends.

Carton L, Cottencin O, Lapeyre-Mestre M, Geoffroy PA, Favre J, Simon N.

Curr Pharm Des. 2015 Jun 18. [Epub ahead of print]

PMID:
26088115
4.

DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder.

Burghardt KJ, Goodrich JM, Dolinoy DC, Ellingrod VL.

Epigenomics. 2015 Jun;7(3):343-52. doi: 10.2217/epi.15.5.

PMID:
26077424
5.

Efficacy and tolerability of treatments for bipolar depression.

Vázquez GH, Holtzman JN, Tondo L, Baldessarini RJ.

J Affect Disord. 2015 Sep 1;183:258-62. doi: 10.1016/j.jad.2015.05.016. Epub 2015 May 19.

PMID:
26042634
6.

Atypical antipsychotics in the treatment of pathological aggression in children and adolescents: literature review and clinical recommendations.

Teixeira EH, Jacintho A, Celeri HV, Dalgalarrondo P.

Trends Psychiatry Psychother. 2013;35(3):151-9.

7.

Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: a meta-analysis.

Bartoli F, Lax A, Crocamo C, Clerici M, Carrà G.

Psychoneuroendocrinology. 2015 Jun;56:179-89. doi: 10.1016/j.psyneuen.2015.03.012. Epub 2015 Mar 14. Review.

PMID:
25827962
8.

Therapeutic drug levels of second generation antipsychotics in youth: a systematic review.

Whitney Z, Boyda HN, Procyshyn RM, Elbe D, Black T, Eslami A, Barr AM.

J Child Adolesc Psychopharmacol. 2015 Apr;25(3):234-45. doi: 10.1089/cap.2014.0044. Epub 2015 Mar 24.

PMID:
25803501
9.

Use of quetiapine in children and adolescents.

Masi G, Milone A, Veltri S, Iuliano R, Pfanner C, Pisano S.

Paediatr Drugs. 2015 Apr;17(2):125-40. doi: 10.1007/s40272-015-0119-3.

PMID:
25686575
11.

Potential use of lurasidone for the treatment of bipolar psychosis.

Carta MG, Moro MF, Nardi AE, Calabrese JR.

Expert Opin Investig Drugs. 2015 Apr;24(4):575-84. doi: 10.1517/13543784.2015.1009976. Epub 2015 Jan 30.

PMID:
25633339
12.

Use of antipsychotic medications in pediatric and young adult populations: future research needs.

Christian RB, Gaynes BN, Saavedra LM, Sheitman B, Wines R, Jonas DE, Viswanathan M, Ellis AR, Woodell C, Carey TS.

J Psychiatr Pract. 2015 Jan;21(1):26-36. doi: 10.1097/01.pra.0000460619.10429.4c.

PMID:
25603449
13.

Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.

Belvederi Murri M, Guaglianone A, Bugliani M, Calcagno P, Respino M, Serafini G, Innamorati M, Pompili M, Amore M.

Drugs R D. 2015 Mar;15(1):45-62. doi: 10.1007/s40268-014-0078-0.

14.

Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine.

Kishi T, Matsunaga S, Matsuda Y, Iwata N.

Neuropsychiatr Dis Treat. 2014 Dec 10;10:2339-51. doi: 10.2147/NDT.S73464. eCollection 2014.

15.

Treatment of aggressive behavior problems in boys with intellectual disabilities using zuclopenthixol.

Hässler F, Dück A, Jung M, Reis O.

J Child Adolesc Psychopharmacol. 2014 Dec;24(10):579-81. doi: 10.1089/cap.2014.0066.

PMID:
25514543
16.

Patterns of initiation of second generation antipsychotics for bipolar disorder: a month-by-month analysis of provider behavior.

Miller CJ, Li M, Penfold RB, Lee AF, Smith EG, Osser DN, Bajor L, Bauer MS.

BMC Psychiatry. 2014 Nov 30;14:339. doi: 10.1186/s12888-014-0339-z.

17.

Evaluating aripiprazole as a potential bipolar disorder therapy for adults.

Moro MF, Carta MG.

Expert Opin Investig Drugs. 2014 Dec;23(12):1713-30. doi: 10.1517/13543784.2014.971152. Epub 2014 Oct 14. Review.

PMID:
25311824
18.

Antipsychotic treatment of schizophrenia: an update.

Bruijnzeel D, Suryadevara U, Tandon R.

Asian J Psychiatr. 2014 Oct;11:3-7. doi: 10.1016/j.ajp.2014.08.002. Epub 2014 Aug 13.

PMID:
25216917
19.

Trends in use of psychotropic medications among patients treated with cholinesterase inhibitors in Japan from 2002 to 2010.

Okumura Y, Togo T, Fujita J.

Int Psychogeriatr. 2015 Mar;27(3):407-15. doi: 10.1017/S1041610214001975. Epub 2014 Sep 12. Erratum in: Int Psychogeriatr. 2015 Mar;27(3):417-8.

PMID:
25213318
20.

Yokukansan and its ingredients as possible treatment options for schizophrenia.

Yu CH, Ishii R, Yu SC, Takeda M.

Neuropsychiatr Dis Treat. 2014 Sep 1;10:1629-34. doi: 10.2147/NDT.S67607. eCollection 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk